Managing SARS.
- 14 August 2003
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 349 (7) , 707-708
- https://doi.org/10.1056/NEJMc031440
Abstract
With regard to the article by Wenzel and Edmond (May 15 issue),1 the management of suspected cases of severe acute respiratory syndrome (SARS) is not harmless. Recently, we admitted a man who had returned from Saigon and had pneumonia diagnosed at the airport. His symptoms included fever, cough, interstitial lung infiltrates, lymphopenia, and elevated lactate dehydrogenase levels. No microbiologic analysis of sputum was performed because of infection-prevention measures.2 Five days after empirical antibiotic therapy began, respiratory failure developed, necessitating admission to the intensive care unit. Prevention measures were then discontinued, since the patient had not been exposed to anyone with a known case of SARS, there had been no cases reported in Saigon, and polymerase-chain-reaction assays of a throat swab were negative for coronavirus.3 Finally, Burkholderia pseudomallei was found in the sputum.Keywords
This publication has 4 references indexed in Scilit:
- Managing SARS amidst UncertaintyNew England Journal of Medicine, 2003
- Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- MelioidosisThe Lancet, 2003
- Endemic Melioidosis in Tropical Northern Australia: A 10‐Year Prospective Study and Review of the LiteratureClinical Infectious Diseases, 2000